2 Days Workshop:FDA Penalties for Regulatory Non-Compliance in the Pharmaceuticals Industry - 2017 in Review

By: Brian G. Nadel, RAC, President of Brian G. Nadel, GMP Consulting, LLC..
Product code: SEM30
Location 1: San Diego CA Jan 30 - 31

Description

Course “FDA Penalties for Regulatory Non-Compliance in the Pharmaceuticals Industry - 2017 in Review“ has been Pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion.

"Each attendee will receive 2-Day workshop materials ,Certificate, Complimentary Breakfast , Lunch & High Tea/Coffee provided by WCS"

This hands-on seminar provides a comprehensive approach to learning how to proactively prevent non-compliance. There will be intensive reviews on the negative consequences of receiving regulatory enforcement actions. FDA Warning Letters are posted publicly on the CDER web site. Your competitors, shareholders, the public and your patients now become aware of your shortfalls. Many Warning Letters today mandate the hiring of third party consultants, which can be quite expensive. An Injunction will require pharmaceutical companies to spend millions of dollars and require years until you “bounce back.” Multimillion disgorgement penalties are being levied along with Injunctions. 

The FDA is increasing its enforcement actions both for domestic and foreign inspections. Enforcement statistics have not been summarized yet because 2017 has not ended yet. We are certainly seeing more Warning Letters and Import Alerts based on Data Integrity (21 CFR Part 11: Electronic Records; Electronic Signatures. In the past FDA used to issue several Warning Letters to the same firms upon consecutive inspections.  Today, after receiving one Warning Letter the next regulatory action is elevated to Import Alert, Consent Decree, and Injunctions for domestic manufacturers.

Senior Management must take the initiative in setting the tone of full compliance:

       • Taking “regulatory risks” may no longer be worth the price of getting caught

       • Planned deviations cannot be used as an excuse for not following your written procedures

       • Retesting into compliance has been unacceptable for many years and will no longer be tolerated

       • Senior officials are being held responsible. Today, these “Captains” may go down with the ship – sent to prison and fined millions of dollars

FDA’s Office of Manufacturing Quality (OMQ) at the Center for Drug Evaluation and Research  (CDER) evaluates compliance with current Good Manufacturing Practice (cGMP) for drugs based on inspection reports and evidence gathered by FDA investigators. The office also develops and implements compliance policy and takes advisory actions to protect the public from adulterated drugs in the U.S. market. This year we have seen:

       • Increased use of Contract Manufacturing Organizations (CMO) has increased the regulatory focus on CMO and requirements for Quality Agreements are being enforced

       • There has been an increase in Warning Letters in 2017

       • An increase in Import Alerts enforcement actions

       • Data Integrity issues are being found more frequently

Areas Covered

•    Introduction and Background
•    Summary and Highlights of 2017 Enforcement Actions
•    Penalties and Negative Financial results of Enforcement Actions
•    ICH Guidelines on Quality Risk Management
•    Adequate Responses to FDA
•    Change in Attitude and Culture
•    Metrics on Improvements

Who will Benefit

•    Drugmakers
•    Devicemakers
•    Biologics firms
•    Diagnostics firms
•    Executive suite
•    Manufacturing/GMP
•    QA/QC
•    Regulatory affairs
•    Strategic planners
•    Legal counsel
•    Consultants

Learning Objectives

This 2 Days Workshop is intended for professionals in the 

•  Pharmaceuticals
•  Biotech
•  Medical Device

Although not presently stated in the draft , the same guide could be used by FDA Regulated Industries personnel.

Course Outline:

Day 1 Schedule

Lecture 1: Introduction and Background

        • Introductions / Participants’ Understanding / Participants’ Objectives for the Course (Please come prepared to discuss)

        • Background

        • Industry Context

        • Key Concepts

 

Lecture 2: Summary and Highlights of 2017 Enforcement Actions

        • Warning Letters

        • Import Alerts

        • Consent Decrees

        • Injunctions

 

Lecture 3: Penalties and Negative Financial results of Enforcement Actions

        • Detailed Costs and Expenditures for Remediation

        • Loss of Sales and Customers

        • Decreases in Patients Access

        • Loss of Good Reputation

        • Loss of Jobs

 

Lecture 4: ICH Guidelines on Quality Risk Management

        • Science Based Quality Risk Management

        • Quality Risk Management Process

        • Initial Risk Assessment

        • Implement & Verify Appropriate Controls

        • Review Risks & Monitor Controls

 

Day 2 Schedule

Lecture 5: Adequate Responses to FDA

        • Comprehensive Corrective and Preventative Action (CAPA) Plans

        • Sincere and Specific timelines

        • Quarterly Follow-ups

        • Adequate but not overwhelming documentation 

        • Training

 

Lecture 6: Change in Attitude and Culture

        • Full Support and Commitment of Senior Management

        • Responsibilities to Customers

        • Proactive Not Reactive

 

Lecture 7: Metrics on Improvements

        • Management Involvement

        • Personnel Involvement

        • Positive Increases in Metrics Lead to Positive Attitudes

        • Incentives and Acknowledgements 

 

Interactive Session:  Group Activities Writing FDA-483 Responses

        • Instructors Evaluation and Recommendations 

 

speaker

Brian G. Nadel, RACPresident of Brian G. Nadel, GMP Consulting, LLC.

Brian G. Nadel is the President/Sole Proprietor of Brian G. Nadel, GMP Consulting, LLC. He has over twenty-five years of diverse experience in: Pharmaceutical Quality Assurance and Quality Systems; FDA Pre-Approval and Inspection Readiness Inspections; International CGMP Auditing for finished drug products, Active Pharmaceutical Ingredients, Fermentation, Process Validation and botanical extraction.

Mr. Nadel utilizes his broad background to assess compliance issues and develop effective, efficient comprehensive systems to ensure CGMP Compliance. He assists pharmaceutical firms in maintaining and developing quality manufacturing operations. He has worked with NDA, ANDA, DMF, BLA and OTC product manufacturers. He has also conducted CGMP training for FDA, Industry and at industry conferences. He has worked to assist clients to comply with the requirements of Consent Decrees. He has used his experience in the pharmaceutical and government regulatory industries to author SOPs in quality and compliance areas.

Mr. Nadel has worked as a Senior Consultant for PAREXEL International. Prior to joining PAREXEL, Mr. Nadel was a Senior Director responsible for Supplier Quality, Risk Management and Anti-Counterfeiting, in the Corporate Quality and Compliance department at Sanofi’s US headquarters in Bridgewater, NJ. Before that, he was the Senior Manager at Forest Laboratories in NY and NJ responsible for Pre-Approval Inspection Readiness and Internal and External audits. At Forest Laboratories, he managed teams that were responsible for receiving first-pass approvals of two blockbuster NDA drug products. He started his career as a Drug Specialist Investigator in FDA’s New York District Office. He was then promoted to the FDA’s Center for Drug Evaluation and Research (CDER) in Rockville, MD, where he served as a Compliance Officer in the Office of Compliance of Compliance, Division of Manufacturing and Product Quality. At CDER, his main responsibility was reviewing recommendations from the district offices for regulatory actions such as Warning Letters, Seizures, Consent Decrees and Injunctions.

Mr. Nadel holds a BA in Microbiology and Parasitology from the State University of New York at Albany, NY and is a certified Regulatory Affairs Professional. He is a member of the Parenteral Drug Association and the Regulatory Affairs Professional Society. Mr. Nadel has spoken at many industry conferences, including three conferences in India in 2017.

Mr. Nadel has just completed his third trip to India in 2017. During these visits, he has been working with Indian Pharma to train them to proactively prevent problems and respond to “issues” with the US FDA. 

30-January-2018 To 31-January-2018 San Diego CA
Seminar One Registration
$ 1295



Special Group Discount Register for Four attendees
$ 3885

Please call any of our customer support on 844-267-7299 to avail the below discount for your Group

2 Attendees - 5% off

3 to 6 Attendees - 10% off

7 to 10 Attendees - 15% off

10+ Attendees - 20% 0ff

Other Modes of Payment

Want to register by Wire Transfer?
Please call any of our customer support on 844-267-7299 to help you completed the transfer.

Want to register by check or PO?
Please call any of our customer support on 844-267-7299 or drop any email to help you completed the purchase.

Download Registration Form

Yes, I want to attend this Seminar

Click here to Download Registration Form

Homewood Suites by Hilton San Diego-Del Mar
11025 Vista Sorrento Parkway, San Diego CA 92130.
Phone: 858.720.9500?

If you need any assistance, please feel free to call at 844-267-7299 

How to Reach

Testimonials

I have attended various seminars from WCS but this "Live" one was incredible. This seminar was excellent.

Pfizer Quality Manager

I liked WCS training style. WCS speakers gave excellent examples to back up what speaker was explaining. Which helped me grasp a better understanding."

RA/QA Manager Abbott

The presenter was excellent session leader, very knowledgeable and well-spoken. The topic was well chosen and interaction between the participants and the presenter was good.

Chief Compliance Officer
 

This was an informative seminar. Provided very valuable insight into how the FDA works. Presenters' experience in real life events and interaction with the FDA is priceless.

Quality Assurance Medtronic

“I enjoyed the training, the instructor was engaging and were able to modify the course to make it more applicable for small group.”

Peter Belsito, Director of Quality TSI

Awesome material covered.  Andbero Magleo, IT Admin Passy-Muir

“Very informative with enough details to start putting together action plans. Susan Murphy, Associate Director, Quality investigation (QA) LFB USA

“I learned a lot from the instructor and trainee good.” David QU, senior Analytical Chemist Dalton Pharma Services.

 

“Well placed, a lot of good information. Good interaction between participants. Held at a good location. More was US based examples given.” Nicola Mootoo, Senior Validation Engineer Shire Pharmaceuticals

 

“Well delivered seminars, right place, good contents.” Evelyn Chang, Corporate manager Genzyme.


“I though the contents of the presentation and the discussion was very good.”Mary Beird, Regulatory Compliance Manager Charles River laboratories International, Inc.

 

“Great session. I learned a lot” Chief HR Professional"

“Wow!  I had an opportunity to attend the HR audit workshop.  It is spectacular and I found it very valuable.
It will help us audit and manage strategic HR issues.” The president of a major insurance and risk management agency.

“I found the audit session very useful; it will help us identify and manage key HR management issues.” A senior auditor

“The session provided important information about HR auditing. It will help us audit critical HR issues and outcomes
 and will help us assess the organization’s culture and values.” A Chief Internal Auditor

“I’ve been doing a lot of research lately on HR audits, trying to find the best system for us.
This session and ELLA seems to really fit the bill for us.” A human resource manager

 

Media Partners

Top Media Partners and Sponsors World Compliance Seminars WCS


speaker

Morf Media, Inc. is shaping the future of enterprise compliance training for the mobile workforce. For the first time, a digital compliance training system, Morf Learning™, provides one to one training to millions on a smart phone or tablet. Now in pilot with more than 100 major companies in the financial services and life sciences industries, Morf Learning is proving to be cost-effective and engaging. Morf Learning delivers three-minute mini lessons with a personalized Virtual Coach™ developed using the Octalysis framework designed by world-renowned gamification leader, Yu-Kai Chou. 


speaker

Benefits of enrolling for Media Partner

Your company Logo on all the mailings before and after the event.

Get 10% discount to media partner's subscribers.

Publish your Logo and company data on the event website.

Publish your Logo on the conference material distributed during the conference.

Media Partner’s brochure distributed along with conference material


speaker

MEDIA PARTNERS WORK TO DO

Publish Banner on the Media Partner website.

Insertion of the WCS event in the event calendar, both printed and/or online.

Announcement article of the conference on the Magazine and/or Website.

Dedicated email blast to all subscribers

Sponsors

Top Sponsors for WCS - World Compliance Seminars


speaker

If you wish to sponsor our event

Please contact us: 

partner@worldcomplianceseminars.com or speak with one of the account manager + 844 267-7299


speaker

$2,000 - Silver Sponsor Package Includes

Company name and logo on all materials related to events, and prominent location on WCS web site and event media releases 

Listing in monthly Community Leader newsletter sent to over 50,000 users. 

1 Free Pass for the 2 Day Workshop

Sponsors materials will be distributed onsite to all the attendees


speaker

$4,000 - Silver Gold Package Includes

Company name and logo on all materials related to events, and prominent location on WCS web site and event media releases 

Listing in monthly Community Leader newsletter sent to over 50,000 users. 

2 Free Pass for the 2 Day Workshop

Sponsors materials will be distributed onsite to all the attendees

15-20 minutes product demo during the live session

San Diego Cabrillo National Monument, San Diego CA

The first European to set foot in California was the Spanish explorer Juan Rodriguez Cabrillo, who stepped on shore near this spot in in 1542. He's the guy they made this statue to look like -

Sea Creatures at Birch Aquarium, San Diego CA

Birch Aquarium is north of San Diego in La Jolla. It's not as big as some of the other aquariums in California or as flashy as the big sea-themed park down the road, but instead just right, fil

Legoland, San Diego CA

Legoland theme park takes its inspiration from Lego toys, those cute little bricks that snap together to build all kinds of fun things. It's one of several Legolands worldwide.

San Diego Zoo Safari Park, San Diego CA

The San Diego Zoo's sister park offers a different kind of animal experience. Its name (Safari Park) is the clue and it indeed offers a more safari-like experience. Lots of large animals live i

Coronado Island, San Diego CA

Coronado isn't really an island but a peninsula - a fact that doesn't get in the way of the name most people use for it. Whatever you call it, it's on a slender strip of land between th

Balboa Park, San Diego CA

Originally built for temporary use during the 1915-16 Panama-California Exposition in San Diego, Balboa Park boasts buildings beautiful enough to be considered attractions in themselves, especially

La Jolla, San Diego CA

In Spanish, La Jolla means "the jewel," an apt name for a pretty, Mediterranean-style seaside town - sitting on cliffs flanking the ocean.
La Jolla visitors like to shop and eat in

Back to Top